Period prevalence and cumulative incidence of lamivudine resistance and its associated factor in chronic hepatitis B patient in Hospital Universiti Sains Malaysia (HUSM)
Background: Lamivudine is an established treatment options for chronic hepatitis B (CHB), however development of viral resistance followed by virological breakthrough made it a less favourable as a first line treatment option. While the alternatives such as entecavir and tenofovir are favoured for...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/46573/1/Dr.%20Mohd%20Sharizan%20Ismail-24%20pages.pdf |